In this Podcast episode Dr. Stefan Walzer confronts the Swiss expert Michael Zuercher with his perspective on Market Access to Switzerland. Furthermore they are discussing the right commercial planning in the context of a successful market access submission in Switzerland. Even though the Swiss market is low in volumes due to a limited number of patients in comparison to other European countries, it is a very attractive market with unique entrance options such as “early paid access”!

Take the chance to stay connected and subscribe with your favorite podcasting platform.

For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de